[Consultation with regard to benefit-risk assessment and possible side effects of a long-term postmenopausal hormone substitution with estrogens-gestagens. New developments in hormone substitution therapy].
Lauritzen
C
C
Forschungsinstitut für Gynäkologische Endokrinologie, Sterilität und Menopause, Ulm.
D000328:Adult; D001943:Breast Neoplasms / Q000139:chemically induced; D004333:Drug Administration Routes; D045166:Estradiol Congeners / Q000009:adverse effects* / Q000494:pharmacology; D015914:Estrogen Replacement Therapy / Q000009:adverse effects* / Q000379:methods; D005260:Female; D005833:Genital Neoplasms, Female / Q000139:chemically induced; D005858:Germany; D006801:Humans; D010817:Physician-Patient Relations; D045167:Progesterone Congeners / Q000009:adverse effects* / Q000494:pharmacology; D012017:Referral and Consultation; D018570:Risk Assessment
D045166:Estradiol Congeners; D045167:Progesterone Congeners